Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Fluorouracil × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 21 Stomach Neoplasms 15 Esophageal Neoplasms 9 Adenocarcinoma Of Esophagus 9 Rectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 6 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Colonic Neoplasms 6 Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Urinary Bladder Neoplasms 3 Lung Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma 3 Oropharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Carcinoma, Pancreatic Ductal 2 Carcinoma 2 Anus Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡